Clarification of dalfampridine labeled indications

J Manag Care Pharm. 2012 Mar;18(2):156. doi: 10.18553/jmcp.2012.18.2.156.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Consensus*
  • Humans
  • Multiple Sclerosis / drug therapy*
  • Pharmacy Service, Hospital / standards*